IN THIS ISSUE

Q&A
Joseph Burns

Health plans are taking steps to implement this promising payment system, but it sure ain’t easy

Peer-Reviewed
Nicole C. Ferko MSc
Natalie Borisova PhD
Parisa Airia, PhD
Using case studies, researchers assess the effect of rebate rates on the cost-effectiveness of two oral bisphosphonates that are competing for tier 2 positioning
Editor's Memo
John Marcille
Legislation & Regulation
John Carroll
The idea is that selling policies across state lines will lower costs and increase the number of insured, but it hasn’t worked that way yet
Medication Management
Tom Reinke

With acquisition costs so low, pharmacies are almost giving away generic statins. How this affects the structure of the pharmacy benefit is yet to be determined.

Tomorrow's Medicine
Thomas Morrow, MD

Stribild, a four-drugs-in-one agent, makes a once complex drug regimen more manageable with better outcomes

News & Commentary
News & Commentary